Repurposing ‘Not Sexy’ Enough
51:15–52:21 · 66s
FDA analyst Heather Stone laments that drug-repurposing research gets less than 1 percent of funding because it’s considered unsexy.
51:15–52:21 · 66s
FDA analyst Heather Stone laments that drug-repurposing research gets less than 1 percent of funding because it’s considered unsexy.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.